Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.


Journal

Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923

Informations de publication

Date de publication:
04 2021
Historique:
received: 12 09 2020
revised: 12 10 2020
accepted: 12 10 2020
pubmed: 19 10 2020
medline: 14 1 2022
entrez: 18 10 2020
Statut: ppublish

Résumé

Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month and 12 months after heart transplantation (HTx) in 104 patients. Detection and characterization of donor specific (DSA) and MHC class-I polypeptide-related sequence A (MICA) antibodies were performed before, 1, 6 and 12 months after transplantation. During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area (P < .001), and progression in mean intimal thickness (IT) (P < .001). DSA and anti-MICA occurred in 17% of all patients, but no significant relationship was observed between presence of DSA/anti-MICA and IT progression within 12 months after HTx. In contrast, we observed significant association between presence of DSA (p=0.031), de-novo DSA (p=0.031), HLA Class II DSA (p=0.017) and media thickness (MT) progression. Results of our study did not identify a direct association between presence of DSA/anti-MICA and intimal thickness progression in an early period after HTx. However, we found significant relationships between DSA and media thickness progression that may identify a newly recognized immune-pathological aspect of CAV.

Identifiants

pubmed: 33069814
pii: S0966-3274(20)30148-9
doi: 10.1016/j.trim.2020.101340
pmc: PMC9114443
mid: NIHMS1643461
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101340

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB004640
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Transpl Immunol. 2011 Sep;25(2-3):124-32
pubmed: 21782945
J Heart Lung Transplant. 2018 May;37(5):537-547
pubmed: 29452978
Hum Immunol. 2010 Dec;71(12):1191-6
pubmed: 20868717
Ultrasound Med Biol. 2013 Jan;39(1):72-88
pubmed: 23141901
Transplant Direct. 2016 Sep 13;2(10):e106
pubmed: 27795988
Circulation. 2001 Aug 7;104(6):653-7
pubmed: 11489770
Circulation. 2007 Sep 11;116(11):1274-82
pubmed: 17709643
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1609-14
pubmed: 24903097
J Am Coll Cardiol. 2005 May 3;45(9):1532-7
pubmed: 15862430
Circulation. 1997 Feb 18;95(4):855-9
pubmed: 9054742
JACC Cardiovasc Imaging. 2012 Jun;5(6):662-3
pubmed: 22698538
J Heart Lung Transplant. 2013 Dec;32(12):1147-62
pubmed: 24263017
Am J Transplant. 2011 Feb;11(2):312-9
pubmed: 21219570
IEEE Trans Med Imaging. 2013 Aug;32(8):1536-49
pubmed: 23649180
Circulation. 2019 Mar 19;139(12):e553-e578
pubmed: 30776902
Clin Transplant. 2018 Nov;32(11):e13416
pubmed: 30276870
J Heart Lung Transplant. 2009 Apr;28(4):305-11
pubmed: 19332255
Med Image Anal. 2018 Dec;50:95-105
pubmed: 30253306
Trends Mol Med. 2010 Mar;16(3):97-106
pubmed: 20153697
J Heart Lung Transplant. 2018 Aug;37(8):992-1000
pubmed: 29706574
Clin Transplant. 2017 Sep;31(9):
pubmed: 28627046
J Am Coll Cardiol. 2005 May 3;45(9):1538-42
pubmed: 15862431
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2359-65
pubmed: 16917106
Transpl Int. 2016 Jan;29(1):63-72
pubmed: 26340387
Transplantation. 2013 Jan 27;95(2):389-96
pubmed: 23325007
Am J Pathol. 1991 Apr;138(4):791-8
pubmed: 2012171
J Heart Lung Transplant. 2016 Jan;35(1):87-91
pubmed: 26422083
Transpl Int. 2014 Aug;27(8):793-804
pubmed: 24725030
Transplantation. 2018 Oct;102(10):e431-e438
pubmed: 29916988
Exp Clin Transplant. 2008 Sep;6(3):229-35
pubmed: 18954302
Circulation. 2020 Jun 16;141(24):1954-1967
pubmed: 32363949
J Heart Lung Transplant. 2005 Nov;24(11):1710-20
pubmed: 16297770

Auteurs

Michal Pazdernik (M)

Department of Cardiology, IKEM, Prague, Czech Republic; Department of Cardiology, 2nd Medical School, Charles University, University Hospital Motol, Prague, Czech Republic. Electronic address: Michal.Pazdernik@email.cz.

Helena Bedanova (H)

Cardiovascular and Transplantation Surgery, Brno, Czech Republic.

Zhi Chen (Z)

Iowa Institute for Biomedical Imaging, The University of Iowa, Iowa City, IA, USA.

Josef Kautzner (J)

Department of Cardiology, IKEM, Prague, Czech Republic.

Vojtech Melenovsky (V)

Department of Cardiology, IKEM, Prague, Czech Republic.

Ivan Malek (I)

Department of Cardiology, IKEM, Prague, Czech Republic.

Antonij Slavcev (A)

Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Michaela Bartonova (M)

Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Vladimir Karmazin (V)

Department of Cardiology, IKEM, Prague, Czech Republic.

Tomas Eckhardt (T)

Department of Cardiology, IKEM, Prague, Czech Republic.

Ales Tomasek (A)

Cardiovascular and Transplantation Surgery, Brno, Czech Republic.

Eva Ozabalova (E)

Department of Cardiovascular Diseases, St. Anne's University Hospital and Masaryk University Brno, Czech Republic.

Tomas Kovarnik (T)

2nd Department of Internal Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.

Peter Wohlfahrt (P)

Center for Cardiovascular Prevention of the First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.

Milan Sonka (M)

Iowa Institute for Biomedical Imaging, The University of Iowa, Iowa City, IA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH